Join HeartFlow
in Orlando

Booth 3245

Connect with Us

More than before.

The non-invasive HeartFlow® FFR CT Analysis provides insight into the lesion-specific physiology of patients with suspected coronary artery disease.

Magnifying glass over document

Clinical Results

  • Greatly reduced unnecessary invasive testing compared to standard pathway 1
    • 61% of patients avoided an invasive angiogram
    • Similar rates of revascularization
    • Zero adverse clinical events among patients whose angiogram was canceled
  • Reduced cost of care by 26% compared to standard pathway 1
  • 200+ published clinical articles
Checkmark in badge

Acceptance

  • Reimbursed by the Centers for Medicare & Medicaid Services
  • Recommended by NICE in the UK for patients with stable recent onset chest pain
  • Determined by Blue Cross Blue Shield Association’s Evidence Street to provide a meaningful improvement in net health outcome
  • Covered by a growing number of major US commercial insurers, including Aetna, Anthem, and numerous other Blue Cross Blue Shield plans
  • Obtained Category III CPT codes from the American Medical Association
Globe

Reach

  • Chosen by physicians for 15,000+ patients
  • Utilized globally at 80+ medical institutions
  • Commercially available in the United States, Canada, Europe and Japan
Lines connecting dots to make a cube shape

Breakthrough Technology

  • Provides actionable patient information to clinicians, with a median return time of less than 5 hours 2

1 Douglas, et al. J Am Coll Cardiol 2016; 68:435-45.
2 As of 31 Jan 2018 and subject to change.

 

Let's Connect at ACC

* Required fields.

Upwards arrow